2-(3,4-Dichlorophenyl)-N-((6-(4-(trifluoromethyl)phenyl)imidazo[2,1-b]thiazol-5-yl)methyl)ethan-1-amine

ID: ALA4574886

PubChem CID: 142505424

Max Phase: Preclinical

Molecular Formula: C21H16Cl2F3N3S

Molecular Weight: 470.35

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  FC(F)(F)c1ccc(-c2nc3sccn3c2CNCCc2ccc(Cl)c(Cl)c2)cc1

Standard InChI:  InChI=1S/C21H16Cl2F3N3S/c22-16-6-1-13(11-17(16)23)7-8-27-12-18-19(28-20-29(18)9-10-30-20)14-2-4-15(5-3-14)21(24,25)26/h1-6,9-11,27H,7-8,12H2

Standard InChI Key:  YFQXADHNTBCBFF-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
   21.2797  -12.8547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2432  -11.5317    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.7840  -12.2066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0294  -11.7640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0498  -12.5811    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.8331  -12.8142    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.2969  -12.1412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8001  -11.4922    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   19.9700  -12.2310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0475  -13.6382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6099  -14.2311    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.3776  -15.0146    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9400  -15.6074    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7078  -16.3909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9125  -16.5761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6801  -17.3588    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2428  -17.9526    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0410  -17.7584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2696  -16.9761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0116  -18.7364    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   19.8854  -17.5490    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   19.5468  -11.5363    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7337  -11.5603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3470  -12.2779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7795  -12.9728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5912  -12.9454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5302  -12.3034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7869  -12.3287    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   16.9701  -11.6607    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   17.0115  -12.9840    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0
  4  2  2  0
  2  3  1  0
  3  1  2  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  4  1  0
  3  9  1  0
  1 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 17 20  1  0
 16 21  1  0
  9 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26  9  1  0
 24 27  1  0
 27 28  1  0
 27 29  1  0
 27 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4574886

    ---

Associated Targets(Human)

NR1I3 Tchem Nuclear receptor subfamily 1 group I member 3 (655 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 470.35Molecular Weight (Monoisotopic): 469.0394AlogP: 6.72#Rotatable Bonds: 6
Polar Surface Area: 29.33Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.43CX LogP: 6.40CX LogD: 4.39
Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.32Np Likeness Score: -1.83

References

1. Liang D, Li L, Lynch C, Mackowiak B, Hedrich WD, Ai Y, Yin Y, Heyward S, Xia M, Wang H, Xue F..  (2019)  Human constitutive androstane receptor agonist DL5016: A novel sensitizer for cyclophosphamide-based chemotherapies.,  179  [PMID:31247375] [10.1016/j.ejmech.2019.06.031]
2. Forman, B M BM and 7 more authors.  1998-10-08  Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta.  [PMID:9783588]
3. Maglich, Jodi M JM and 10 more authors.  2003-05-09  Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes.  [PMID:12611900]
4. Huang, Wendong W, Zhang, Jun J, Wei, Ping P, Schrader, William T WT and Moore, David D DD.  2004-10  Meclizine is an agonist ligand for mouse constitutive androstane receptor (CAR) and an inverse agonist for human CAR.  [PMID:15272053]
5. Gege, Christian C, Schlüter, Thomas T and Hoffmann, Thomas T.  2014-11-15  Identification of the first inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for RORβ and RORγt.  [PMID:25305688]
6. Pellicciari, Roberto R and 12 more authors.  2016-10-13  Discovery of 3α,7α,11β-Trihydroxy-6α-ethyl-5β-cholan-24-oic Acid (TC-100), a Novel Bile Acid as Potent and Highly Selective FXR Agonist for Enterohepatic Disorders.  [PMID:27652492]

Source